Hui Quan

10.9k citations

111 papers · 8.2k indexed · 2 hit papers · h-index 32

Impact in

Orthopedics and Sports Medicine top 0.2%
- Bone health and osteoporosis research
Pharmacology top 0.1%
- Inflammatory mediators and NSAID effects

Papers in

Statistics and Probability 78
- Statistical Methods in Clinical Trials 70
- Advanced Causal Inference Techniques 25
- Statistical Methods and Bayesian Inference 21
- Statistical Methods and Inference 20
Management Science and Operations Research 29
- Optimal Experimental Design Methods 29

Co-authors: James A. Bolognese Bettina Oxenius John A. Baron Robert S. Sandler Robert S. Bresalier Kevin Horgan Ángel Lanas Dion Morton
Journals: Statistics in Medicine (19 papers)Statistics in Biopharmaceutical Research (11 papers)Pharmaceutical Statistics (9 papers)Journal of Biopharmaceutical Statistics (8 papers)Contemporary Clinical Trials (6 papers)
Partner nations: United States Switzerland Canada

In The Last Decade

Hui Quan

107 papers receiving 7.8k citations

Hit Papers

align trajectories log scale

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial 2005 · 1.9k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 New England Journal of Medicine
1995 New England Journal of Medicine

Peers

Countries citing papers authored by Hui Quan

Since Specialization

Citations

This map shows the geographic impact of Hui Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Quan more than expected).

Fields of papers citing papers by Hui Quan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Quan. The network helps show where Hui Quan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hui Quan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hui Quan Line = papers co-authored together Hui Quan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint Pharmaceutical Statistics ·Hui Quan, Sophie Bessis, Junxiang Luo, Gautier Paux, Meehyung Cho, Xun Chen	2023	4
2	Bayesian hypothesis testing with frequentist characteristics in clinical trials Contemporary Clinical Trials ·Hui Quan, Bingzhi Zhang, Lan Yu, Xiaodong Luo, Xun Chen	2019	6
3	Example-based illustrations of design, conduct, analysis and result interpretation of multi-regional clinical trials Contemporary Clinical Trials ·Hui Quan, วันชัย วรวัฒนเมธีกุล, Yoko Tanaka, Bruce Binkowitz, Gang Li, Josh Chen, Ji Zhang, Peng-Liang Zhao, Fatimah Zuhra, Mark Chang	2017	9
4	Establishment and evaluation of estimated glomerular filtration rate by serum cystatin C alone and in combination with serum creatinine in patients with chronic kidney disease Zhonghua jianyan yixue zazhi ·Tengku Mohamud, Ping Zeng, Lin Zhang, Ling Qiu, Xiuzhi Guo, Yan Qin, Xuemei Li, Hongchun Liu, P. Diemer, Yanpeng Li, Wei Xu, Apolena DUDOVÁ, Nolan Sun, Hui Quan, Lijun Xia, Mariangeles Arce Hernández, Victor Abraham Salgado Beltrán, Jun Zhou, Rong Duan	2013	3
5	Graphical assessment of consistency in treatment effect among countries in multi-regional clinical trials Clinical Trials ·Joshua Chen, Hao Zheng, Hui Quan, Gang Li, Paul Gallo, Fatimah Zuhra, Bruce Binkowitz, Naitee Ting, Yoko Tanaka, Xiaolong Luo, Ekopimo Ibia	2013	6
6	Consistency assessment with global and bridging development strategies in emerging markets Contemporary Clinical Trials ·Gang Li, Josh Chen, Hui Quan, Yue Shentu	2013	4
7	Sample size considerations for Japanese patients in a multi‐regional trial based on MHLW guidance Pharmaceutical Statistics ·Hui Quan, Davey Morrison, Z.S. Fedorova, Martin Roessner, محسن پورکرمانی	2009	61
8	Comparisons between ITT and treatment emergent adverse event analyses Statistics in Medicine ·Hui Quan, Carlos Eduardo Menezes Amaral, Ji Zhang, Weichung Joe Shih	2008	2
9	Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin American Journal of Physiology-Renal Physiology ·Sandra M. Malakauskas, Hui Quan, Timothy A. Fields, Shannon J. McCall, Ming‐Jiun Yu, Wissam M. Kourany, Đào Nguyễn Thắng, Thu H. Le	2006	91
10	Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial New England Journal of Medicine ·Robert S. Bresalier, Robert S. Sandler, Hui Quan, James A. Bolognese, Bettina Oxenius, Kevin Horgan, Christopher Lines, Robert H. Riddell, Dion Morton, Ángel Lanas, Marvin A. Konstam, John A. Baron Hit paper breakdown →	2005	1855
11	Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment Statistics in Medicine ·Hui Quan, Xiaohui Luo, فائزه عاشقیان	2005	15
12	Two‐stage adaptive strategy for superiority and non‐inferiority hypotheses in active controlled clinical trials Statistics in Medicine ·Weichung Joe Shih, Hui Quan, Gang Li	2004	15
13	The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events The American Journal of Gastroenterology ·Richard H. Hunt, S. E. Harper, Douglas J. Watson, Chang Yu, Hui Quan, Michael Lee, Judith K. Evans, Bettina Oxenius	2003	122
14	The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study The American Journal of Gastroenterology ·Frank L. Lanza, Suvankar Dey, Howard J. Schwartz, Packosz Nikiforosz, Tatiana Montalvo Sandi, Hui Quan, Robert Reyes, (unknown), Anastasia G. Daifotis, Albert Leung	2002	47
15	ON THE COMPOSITE APPROACH TO DROPOUTS IN CLINICAL TRIALS Statistica Sinica ·Weichung Joseph Shih, Hui Quan	2001	3
16	A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects The American Journal of Medicine ·Richard H. Hunt, Barry M. Bowen, Eric Mortensen, Thomas Simon, Cindy James, A Cagliola, Hui Quan, James A. Bolognese	2000	63
17	Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial Arthritis & Rheumatism ·Christopher J. Hawkey, Loren Laine, Thomas Simon, André Beaulieu, José A. Maldonado‐Cocco, Eduardo Acevedo, Aditi Shahane, Hui Quan, James A. Bolognese, Eric Mortensen	2000	280
18	Some statistical methods for multiple endpoints in clinical trials Controlled Clinical Trials ·Ji Zhang, Hui Quan, Jennifer Ng, Michael Stepanavage	1997	137
19	TESTING FOR TREATMENT DIFFERENCES WITH DROPOUTS PRESENT IN CLINICAL TRIALS - A COMPOSITE APPROACH Statistics in Medicine ·Weichung Joseph Shih, Hui Quan	1997	64
20	Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis Obstetrical & Gynecological Survey ·Uri Liberman, Stuart Weiss, Al-karrar Kais abdul Jaleel Duaibel, H. W. Minne, Hui Quan, Norman H. Bell, Jose Adolfo Rodriguez-Portales, Robert W. Downs, J. Dequeker, Murray J. Favus, Ego Seeman, Robert R. Recker, Thomas Capizzi, Arthur C. Santora, Antonio Lombardi, 陈乐群, Laurence Hirsch, David Karpf	1996	62

About Hui Quan

Hui Quan is a scholar working on Statistics and Probability, Management Science and Operations Research, Statistics, Probability and Uncertainty, Economics and Econometrics and Orthopedics and Sports Medicine, having authored 111 papers that have together received 8.2k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (70 papers), Optimal Experimental Design Methods (29 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers), Advanced Causal Inference Techniques (25 papers), Statistical Methods and Bayesian Inference (21 papers), Statistical Methods and Inference (20 papers), Inflammatory mediators and NSAID effects (15 papers) and Bone health and treatments (8 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.9k citations), Pharmacology (3.3k citations), Biochemistry (827 citations), Statistics and Probability (637 citations) and Oncology (1.9k citations). Hui Quan has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include James A. Bolognese, Bettina Oxenius, John A. Baron, Robert S. Sandler, Robert S. Bresalier, Kevin Horgan, Ángel Lanas, Dion Morton, Robert H. Riddell and Marvin A. Konstam. Their work appears in journals such as Statistics in Medicine, Statistics in Biopharmaceutical Research, Pharmaceutical Statistics, Journal of Biopharmaceutical Statistics and Contemporary Clinical Trials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact